|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Apr 28, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||||||||
| Assets | |||||||||||||||
| Cash | |||||||||||||||
| Deferred offering costs | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| Total current assets | |||||||||||||||
| Prepaid expenses - non-current portion | |||||||||||||||
| Cash and investments held in Trust Account | |||||||||||||||
| Total Assets | |||||||||||||||
| Liabilities, Temporary Equity, and Shareholders’ Deficit | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Payable — related party | |||||||||||||||
| Promissory note — related party | |||||||||||||||
| Promissory notes - related party | |||||||||||||||
| Payable - related party | |||||||||||||||
| Related Party | |||||||||||||||
| Total payable - related party | |||||||||||||||
| Working Capital Loan - related party | |||||||||||||||
| Extension Loan - related party | |||||||||||||||
| Total Current Liabilities | |||||||||||||||
| Deferred underwriters' discount | |||||||||||||||
| Deferred underwriters’ discount | |||||||||||||||
| Deferred underwriters’ discount | |||||||||||||||
| Total Liabilities | |||||||||||||||
| Ordinary shares subject to possible redemption, 1,116,476 and 3,112,998 shares at redemption value of $12.80 and $11.87 per share as of September 30, 2025 and December 31, 2024, respectively | |||||||||||||||
| Shareholders’ Deficit: | |||||||||||||||
| Preference shares, $0.0001 par value, 1,000,000 shares authorized, none issued and outstanding | |||||||||||||||
| Ordinary shares, value | |||||||||||||||
| Class A Ordinary Shares | |||||||||||||||
| Class B Ordinary Shares | |||||||||||||||
| Total ordinary shares, value | |||||||||||||||
| Class B ordinary shares, $0.0001 par value, 20,000,000 shares authorized, 2,012,500 shares issued and outstanding | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total Shareholders’ Deficit | |||||||||||||||
| Total Liabilities, Temporary Equity and Shareholders’ Deficit |
Loading...
